Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement

Abstract: Patients with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) with central nervous system (CNS) involvement (CNS B-ALL) have poor outcomes and were frequently excluded from CD19-targeting chimeric antigen receptor (CAR) T-cell clinical trials. The efficacy and safety...

詳細記述

書誌詳細

出版年:	Blood Advances
主要な著者:	Ibrahim N. Muhsen, Gregory W. Roloff, Rawan Faramand, Tamer Othman, Yannis Valtis, Noam E. Kopmar, Simone E. Dekker, Matthew Connor, Santiago Mercadal, Timothy E. O'Connor, Kaitlyn C. Dykes, Mohamed Ahmed, Nikeshan Jeyakumar, Amy Zhang, Katharine Miller, Katherine C. Sutherland, Caitlin Guzowski, Vishal K. Gupta, Navneet Majhail, Minoo Battiwalla, Melhem M. Solh, Shahbaz A. Malik, John Mathews, Caspian H. Oliai, Paul Shaughnessy, Luke Mountjoy, Catherine J. Lee, Aaron C. Logan, Stephanie B. Tsai, Jessica T. Leonard, Marc Schwartz, Joshua P. Sasine, Muthu Kumaran, Noelle Frey, Jae H. Park, Divya Koura, Ryan D. Cassaday, Bijal D. Shah, Ibrahim Aldoss, Lori S. Muffly, LaQuisa C. Hill
フォーマット:	論文
言語:	英語
出版事項:	Elsevier 2025-08-01
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S247395292500271X